ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention

Impact of Final Activated Clotting Time After Transradial Coronary Stenting With Maximal Antiplatelet Therapy

(2009) Olivier F. Bertrand et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial

(2008) G. Montalescot et al.   EUROPEAN HEART JOURNAL

The CIAO (Coronary Interventions Antiplatelet-based Only) Study

(2008) Eugenio Stabile et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions

(2008) Gjin Ndrepepa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary Intervention

(2008) Adnan Kastrati et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bivalirudin during Primary PCI in Acute Myocardial Infarction

(2008) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE